Top

Published in:

01-10-2007 | Original Article

Validation of a modified Thai version of the Western Ontario and McMaster (WOMAC) osteoarthritis index for knee osteoarthritis

Authors: Vilai Kuptniratsaikul, Manee Rattanachaiyanont

Published in: Clinical Rheumatology | Issue 10/2007

Abstract

The aim of this study was to evaluate the psychometric properties (validity and reliability) of the Thai version of the Western Ontario and McMaster (WOMAC) index in knee osteoarthritis (OA) patients. After permission from the copyright holder of the WOMAC index was obtained, the questionnaire was translated into Thai, backtranslated, tested for face and content validities, and then modified. A convergent validity was evaluated in 114 patients with knee OA by comparing the scores of a modified Thai WOMAC index to those of the algofunctional Lequesne index. A test–retest reliability was evaluated in 89 patients who answered the modified Thai WOMAC index twice at 3-week intervals. The statistical analyses for the content validity were index of content validity (ICV), floor and ceiling effects, and skewness of distribution; for the convergent validity was Spearman’s correlation; for the test–retest reliability were Spearman’s correlation and intraclass correlation; and for the internal consistency was Chronbach’s α. The Thai WOMAC index had face validity. The ICV of the content validity ranged from 0.25–1.00. Two items (F05 and F12 of the original 24-item WOMAC index) that had an ICV of 0 were removed from the modified Thai version. The modified 22-item Thai WOMAC index had convergent validity to the algofunctional Lequesne index in pain and function dimensions (Spearman’s correlation coefficients were 0.66 and 0.69, respectively). The test–retest reliability had correlation coefficients ranging from 0.65 to 0.71. The internal consistency had an α ranging from 0.85 to 0.97. In conclusion, the modified Thai WOMAC index had acceptable psychometric properties for Thai patients with knee OA.

Felson DT, Naimark A, Anderson J et al (1987) The prevalence of knee osteoarthritis in the elderly: the Framingham osteoarthritis study. Arthritis Rheum 30:914–918PubMedCrossRef

Lawrence RC, Hochberg MC, Kelsey JL et al (1989) Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 16:427–441PubMed

Puett DW, Griffin MR (1994) Published trials of nonmedicinal and noninvasive therapies for hip and knee osteoarthritis. Ann Intern Med 121:133–140PubMed

Davis MA (1988) Epidemiology of osteoarthritis. Clin Geriatr Med 4:241–255PubMed

Kuptniratsaikul V, Tosayanonda O, Nilganuwong S et al (2002) The epidemiology of osteoarthritis of the knee in elderly patients living in an urban area of Bangkok. J Med Assoc Thai 85:154–161PubMed

Rejeski WJ, Shumaker S (1994) Knee osteoarthritis and health-related quality of life. Med Sci Sports Exerc 26:1441–1445PubMed

Smidt N, de Vet HC, Bouter LM et al (2005) Effectiveness of exercise therapy: a best-evidence summary of systematic reviews. Aust J Physiother 51:71–85PubMed

Fransen M, McConnell S, Bell M (2003) Exercise for osteoarthritis of the hip or knee. Cochrane Database Syst Rev 3:CD004286PubMed

Brosseau L, Yonge KA, Robinson V et al (2003) Thermotherapy for treatment of osteoarthritis. Cochrane Database Syst Rev 4:CD004522PubMed

10.

Bellamy N, Campbell J, Robinson V et al (2005) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 18:CD005321

11.

Bellamy N, Buchanan WW, Goldsmith CH et al (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840PubMed

12.

Lequesne MG, Mery C, Samson M et al (1987) Indexes of severity for osteoarthritis of the hip and knee. Scand J Rheumatol 65(Suppl):85–89

13.

Wright JG, Young NL (1997) The patient-specific index: asking patients what they want. J Bone Joint Surg Am 79:974–983PubMed

14.

Meenan RF, Gertman MP, Mason JH (1980) Measuring health status in arthritis. The Arthritis Impact Measurement Scales. Arthritis Rheum 23:146–152PubMedCrossRef

15.

Escobar A, Quintana JM, Bilbao A et al (2002) Validation of the Spanish version of the WOMAC questionnaire for patients with hip or knee osteoarthritis. Clin Rheumatol 21:466–471PubMedCrossRef

16.

Thumboo J, Chew LH, Soh CH (2001) Validation of the Western Ontario and McMaster University osteoarthritis index in Asians with osteoarthritis in Singapore. Osteoarthr Cartil 9:440–446PubMedCrossRef

17.

Guermazi M, Poiraudeau S, Yahia M et al (2004) Translation, adaptation and validation of the Western Ontario and McMaster Universities osteoarthritis index (WOMAC) for an Arab population: the Sfax modified WOMAC. Osteoarthr Cartil 12:459–468PubMedCrossRef

18.

Salaffi F, Leardini G, Canesi B et al (2003) Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) osteoarthritis index in Italian patients with osteoarthritis of the knee. Osteoarthr Cartil 11:551–560PubMedCrossRef

19.

Bae SC, Lee HS, Yun HR et al (2001) Cross-cultural adaptation and validation of Korean Western Ontario and McMaster Universities (WOMAC) and Lequesne osteoarthritis indices for clinical research. Osteoarthr Cartil 9:746–750PubMedCrossRef

20.

Stucki G, Sangha O, Stucki S et al (1998) Comparison of the WOMAC (Western Ontario and McMaster Universities) osteoarthritis index and a self-report format of the self-administered Lequesne-Algofunctional index in patients with knee and hip osteoarthritis. Osteoarthr Cartil 6:79–86PubMedCrossRef

21.

Hashimoto H, Hanyu T, Sledge CB et al (2003) Validation of a Japanese patient-derived outcome scale for assessing total knee arthroplasty: comparison with Western Ontario and McMaster Universities osteoarthritis index (WOMAC). J Orthop Sci 8:288–293PubMedCrossRef

22.

Altman RD, Bloch DA, Bole GG Jr et al (1986) Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 29:1039–1049PubMedCrossRef

23.

Brazier JE, Harper R, Munro J et al (1999) Generic and condition-specific outcome measures for people with OA of the knee. Rheumatology 38:870–877PubMedCrossRef

24.

Lequesne MG (1997) The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 24:779–781PubMed

25.

Tuzun EH, Eker L, Aytar A et al (2005) Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthr Cartil 13:28–33PubMedCrossRef

26.

Wolfe F, Kong SX (1999) Rasch analysis of the Western Ontario MacMaster questionnaire (WOMAC) in 2205 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Ann Rheum Dis 58:563–568PubMed

27.

Guccione AA, Felson DT, Anderson JJ (1990) Defining arthritis and measuring functional status in elders: methodological issues in the study of disease and physical disability. Am J Public Health 80:945–949PubMedCrossRef

Title: Validation of a modified Thai version of the Western Ontario and McMaster (WOMAC) osteoarthritis index for knee osteoarthritis
Authors: Vilai Kuptniratsaikul
Manee Rattanachaiyanont
Publication date: 01-10-2007
Publisher: Springer-Verlag
Published in: Clinical Rheumatology / Issue 10/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-007-0560-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2007

Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus

Latitude gradient influences the age of onset in rheumatoid arthritis patients

Systemic polyarteritis nodosa associated with acute Epstein-Barr virus infection

Unusual presentation of triple A syndrome mimicking Sjögren’s syndrome

Specificity and sensitivity of anti-β2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome

Severe limb necrosis: primary thrombotic microangiopathy or “seronegative” catastrophic antiphospholipid syndrome? A diagnostic dilemma

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials